Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis
To estimate the prevalence of mortality among patients that develop adverse drug reactions during hospitalisation (ADRIn), to examine heterogeneity through subgroup analysis and to identify system-organ class (SOC) and their causative drugs.
Two investigators searched PubMed, Google Scholar and related bibliography for studies reporting ADRIn-related mortality data. The primary outcome was to compute overall prevalence of fatal ADRIn (95% CI) using double arcsine method. We explored the heterogeneity (I2) in its estimation based on study design, study population and data collection methods. The secondary outcomes were the pattern of fatal reactions and their causative drugs. PROSPERO register number—CRD42018090331.
Out of 349 full text assessed, 48 studies satisfying the selection criteria were included. The fatal ADRIn prevalence was 0.11% (95% CI 0.06–0.18%; I2 = 93%). The fatal ADRIn prevalence ranged from 0.03% (I2 = 0%) in all ages to 0.27% (I2 = 90%) in elderly population studies. Elderly studies varied for all study characteristics. Among study wards, a higher trend of prevalence was observed in ‘internal medicine and ICU’ (0.46%, I2 = 51%) and ‘neonatal/paediatric ward and ICU’ (0.34%, I2 = 58%) studies. The commonly involved SOC were ‘gastrointestinal disorders’ (28.79%), ‘blood and lymphatic system disorders’ (19.69%) and ‘renal and urinary disorders’ (13.64%). Most commonly observed causative drug-fatal ADRIn pairs were antithrombotics and nonsteroidal anti-inflammatory drugs induced gastrointestinal bleeding, and antineoplastic agents induced cytopenia.
ADRIn is an important cause of mortality. Age groups and study wards have important influence on prevalence of fatal ADRIn and its heterogeneity across studies. Few class drugs contribute to sizable proportion of ADRIn-related mortality.
KeywordsAdverse drug reactions Drug safety Hospital mortality Pharmacoepidemiology Antithrombotic agents Antineoplastic agents Nonsteroidal anti-inflammatory drugs
- 19.Alsbou M (2010) Incidence of adverse drug reactions in Alkarak hospital: a pilot study. J Med J 44(4):442–446Google Scholar
- 25.de Las Salas R, Díaz-Agudelo D, Burgos-Flórez FJ, Vaca C, Serrano-Meriño DV (2016) Adverse drug reactions in hospitalized Colombian children. Colomb Med (Cali) 47(3):142–147Google Scholar
- 29.El Sebaee HA, El Salam Seloma YA (2013) Adverse drug reactions among critically ill patients at Cairo University Hospital: frequency and outcomes. J Biol Agr Healthc 3(13):5–13Google Scholar
- 32.Ganeva M, Gancheva T, Troeva J, Gancheva D, Hristakieva E (2016) A study of adverse drug reactions in hospitalized patients in relation to age. Eur J Clin Pharm 18(3):154–162Google Scholar
- 36.Haile DB, Ayen WY, Tiwari P (2013) Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India. Ethiop J Health Sci 23(1):39–48Google Scholar
- 39.Kathiria JM, Sattigeri BM, Desai PM, Patel SP (2013) A study of adverse drug reactions in patients admitted to intensive care unit of a tertiary care teaching rural hospital. Int J Pharm Pharm Sci 5(1):160–163Google Scholar
- 43.Kourorian Z, Fattahi F, Pourpak Z, Rasoolinejad M, Gholami K (2009) Adverse drug reactions in an Iranian department of adult infectious diseases. East Mediterr Health J 15(6):1351–1357Google Scholar
- 45.Mandha M, Reddy KP, Reddy KP (2013) Evaluation of adverse drug reactions in pediatric patients. Indian J Pharm P 6(3):32–35Google Scholar
- 55.Sivasankaran P, Gupta M, Satyanarayan RB, Durai R (2016) Pattern of adverse drug reactions in a govt. district headquarters hospital in Tamilnadu, India. Indian J Pharm P 9(1):33–36Google Scholar
- 56.Tangiisuran B, Davies JG, Wright JE, Rajkumar C (2012) Adverse drug reactions in a population of hospitalized very elderly patients. Drugs Aging 29(8):669–679Google Scholar
- 59.Tumwikirize WA, Ogwal-Okeng JW, Vernby A, Anokbonggo WW, Gustafsson LL, Lundborg SC (2011) Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci 11(1):72–78Google Scholar
- 65.Alhawassi TM, Krass I, Bajorek BV, Pont LG (2014) A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 9:2079–2086Google Scholar
- 76.Lamberts M, Lip GY, Hansen ML, Lindhardsen J, Olesen JB, Raunsø J et al (2014) Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. Ann Intern Med 161(10):690–698CrossRefGoogle Scholar
- 83.Spigaglia P (2016) Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection. Ther Adv Infect Dis 3(1):23–42Google Scholar
- 86.Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R (2007) Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 9(1):60–68Google Scholar